In8Bio (INAB) Accumulated Expenses (2020 - 2026)
In8Bio (INAB) reported Accumulated Expenses of $761,000 for Q2 2026, up 19.8% from $635,000 a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, In8Bio posted Accumulated Expenses of $1.63 million, up 56.0% from FY2024.
- Accumulated Expenses has a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $1.05 million in FY2024 (-64.6%), $2.96 million in FY2023 (+26.2%), $2.34 million in FY2022 (+89.6%) and $1.24 million in FY2021 (-30.5%).
- Five-year quarterly Accumulated Expenses spans a low of $418,000 in Q3 2025 and a high of $2.96 million in Q4 2023.
- Year over year, Accumulated Expenses gained in three of the last eight quarters, with an average decline of 21.8%.
- The high point for year-over-year Accumulated Expenses in five years was Q3 2022 (growth of 242.5%); the low point was Q3 2024 (a decline of 68.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $681,000 (Q1 2026), $1.63 million (Q4 2025) and $418,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 761,000.00 |
| Mar 31, 2026 | 681,000.00 |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 418,000.00 |
| Jun 30, 2025 | 635,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 769,000.00 |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 895,000.00 |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.49 Mn |
| Dec 31, 2022 | 2.34 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 1.24 Mn |
| Sep 30, 2021 | 840,000.00 |
API Access
In8Bio Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();